Normal tissue reactions in mice after combined treatment with metoclopramide and ionizing radiation.

Abstract

We have previously shown that metoclopramide potentiates the effect of ionizing radiation and cisplatin treatment of human squamous cell carcinomas from the head and neck region xenografted to nude mice. In the present tumor study, the dose scheduling of metoclopramide in combination with radiation was evaluated, and metoclopramide was shown to be most effective in potentiating the cytotoxic effect of radiation when administered one hour before radiation. The effect of radiation in combination with metoclopramide on normal tissue was also studied in two well-established models. Acute skin reactions to radiation exposure were studied in 129-type mice, and metoclopramide did not enhance the acute skin reaction in this in vivo model. Survival after whole body irradiation was studied in heterozygote Balb/c nu/+ mice as a measure of bone marrow toxicity. Metoclopramide was not found to affect the LD50/30 in this in vivo model. The absence of potentiation of radiation damage to normal tissue in these animal studies, makes metoclopramide an interesting possibility for future clinical evaluation.

• Authors: S Lybak, E Kjellén, P Nilsson, A Tomaszewicz, J Wennerberg, R W Pero
• Journal: Acta oncologica (Stockholm, Sweden) (Acta Oncol) Vol. 31 Issue 4 Pg. 469-74 ( 1992) ISSN: 0284-186X [Print] England
• PMID: 1632984 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Radiation-Sensitizing Agents
• Metoclopramide

Topics

• Animals
• Carcinoma, Squamous Cell (radiotherapy)
• Drug Administration Schedule
• Female
• Humans
• Male
• Metoclopramide (administration & dosage, pharmacology)
• Mice
• Mice, Inbred BALB C
• Mice, Nude
• Neoplasm Transplantation
• Radiation-Sensitizing Agents (administration & dosage, pharmacology)
• Radiotherapy Dosage
• Skin (radiation effects)
• Whole-Body Irradiation